This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Company Filing History:
1 out of 834,307 Years Active: 2003
Title: Carsten Schou: Innovator in Peptide Nucleic Acid Technology
Introduction
Carsten Schou is a notable inventor based in Holte, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of novel drugs aimed at combating infectious microorganisms. His innovative work focuses on enhancing the properties of peptide nucleic acid (PNA) molecules.
Latest Patents
Carsten Schou holds a patent for "Modified peptide nucleic acid (PNA) molecules." This invention relates to novel drugs that can be utilized in the fight against infectious microorganisms, especially bacteria. The patent describes PNA sequences that are modified by conjugating cationic peptides to the PNA moiety, resulting in new PNA molecules that exhibit improved anti-infective properties. He has 1 patent to his name.
Career Highlights
Throughout his career, Carsten Schou has demonstrated a commitment to advancing medical science through innovative research. His work has the potential to lead to significant breakthroughs in the treatment of bacterial infections, which is a critical area of concern in modern medicine.
Collaborations
Carsten has collaborated with several professionals in his field, including Henrik Frydenlund Hansen and Leila Malik. These collaborations have likely contributed to the development and refinement of his innovative ideas and patents.
Conclusion
Carsten Schou is a distinguished inventor whose work in peptide nucleic acid technology holds promise for the future of infectious disease treatment. His contributions to biotechnology are noteworthy and reflect his dedication to improving health outcomes through innovation.